rationale for T-cell-based immunotherapy. *Cancer Immunol Immunother* 66: 119–128

Sundby Hall K, Bruland ØS, Bjerkehagen B, Zaikova O, Engellau J, Hagberg O, Hansson L, Hagberg H, Ahlström M, Knobel H *et al* (2018) Adjuvant chemotherapy and postoperative radiotherapy in high-risk soft tissue sarcoma patients defined by biological risk factors-A Scandinavian Sarcoma Group study (SSG XX). *Eur J Cancer* 99: 78–85

Suzuki K, Fueyo J, Krasnykh V, Reynolds PN, Curiel DT, Alemany R (2001) A conditionally replicative adenovirus with enhanced infectivity shows improved oncolytic potency. *Clin Cancer Res* 7: 120–126

Sys GML, Lapeire L, Stevens N, Favoreel H, Forsyth R, Bracke M, De Wever O (2013) The in ovo CAM-assay as a xenograft model for sarcoma. *J Vis Exp* 77: e50522

Tamaki S, Fukuta M, Sekiguchi K, Jin Y, Nagata S, Hayakawa K, Hineno S, Okamoto T, Watanabe M, Woltjen K *et al* (2015) SS18-SSX, the oncogenic fusion protein in synovial sarcoma, is a cellular context-dependent epigenetic modifier. *PLoS ONE* 10: e0142991

Tarnowski M, Grymula K, Liu R, Tarnowska J, Drukala J, Ratajczak J, Mitchell RA, Ratajczak MZ, Kucia M (2010) Macrophage migration inhibitory factor is secreted by rhabdomyosarcoma cells, modulates tumor metastasis by binding to CXCR4 and CXCR7 receptors and inhibits recruitment of cancer-associated fibroblasts. *Mol Cancer Res* 8: 1328–1343

Taylor BS, Barretina J, Maki RG, Antonescu CR, Singer S, Ladanyi M (2011) Advances in sarcoma genomics and new therapeutic targets. *Nat Rev Cancer* 11: 541–557

Tazawa H, Hasei J, Yano S, Kagawa S, Ozaki T, Fujiwara T (2020) Bone and soft-tissue sarcoma: a new target for telomerase-specific oncolytic virotherapy. *Cancers (Basel)* 12: 478

Tellez-Gabriel M, Brown HK, Young R, Heymann M-F, Heymann D (2016) The challenges of detecting circulating tumor cells in sarcoma. *Front Oncol* 6: 202

Tellez-Gabriel M, Heymann M-F, Heymann D (2019) Circulating tumor cells as a tool for assessing tumor heterogeneity. *Theranostics* 9: 4580–4594

Thanindratarn P, Dean DC, Nelson SD, Hornicek FJ, Duan Z (2019) Advances in immune checkpoint inhibitors for bone sarcoma therapy. *J Bone Oncol* 15: 100221

Théoleyre S, Mori K, Cherrier B, Passuti N, Gouin F, Rédini F, Heymann D (2005) Phenotypic and functional analysis of lymphocytes infiltrating osteolytic tumors: use as a possible therapeutic approach of osteosarcoma. *BMC Cancer* 5: 123

Théry C, Witwer KW, Aikawa E, Alcaraz MJ, Anderson JD, Andriantsitohaina R, Antoniou A, Arab T, Archer F, Atkin-Smith GK *et al* (2018) Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. *J Extracell Vesicles* 7: 1535750

Thiel U, Koscielniak E, Blaeschke F, Grunewald TGP, Badoglio M, Diaz MA, Paillard C, Prete A, Ussowicz M, Lang P *et al* (2013) Allogeneic stem cell transplantation for patients with advanced rhabdomyosarcoma: a retrospective assessment. *Br J Cancer* 109: 2523–2532

Tiriac H, Belleau P, Engle DD, Plenker D, Deschênes A, Somerville TDD, Froeling FEM, Burkhart RA, Denroche RE, Jang G-H *et al* (2018) Organoid profiling identifies common responders to chemotherapy in pancreatic cancer. *Cancer Discov* 8: 1112–1129

Tirode F, Surdez D, Ma X, Parker M, Le Deley MC, Bahrami A, Zhang Z, Lapouble E, Grossetête-Lalami S, Rusch M *et al* (2014) Genomic landscape of Ewing sarcoma defines an aggressive subtype with co-association of STAG2 and TP53 mutations. *Cancer Discov* 4: 1342–1353

Tomazou EM, Sheffield NC, Schmidl C, Schuster M, Schönegger A, Datlinger P, Kubicek S, Bock C, Kovar H (2015) Epigenome mapping reveals distinct modes of gene regulation and widespread enhancer reprogramming by the oncogenic fusion protein EWS-FLI1. *Cell Rep* 10: 1082–1095

Tornin J, Martinez-Cruzado L, Santos L, Rodriguez A, Núñez L-E, Oro P, Hermosilla MA, Allonca E, Fernández-García MT, Astudillo A *et al* (2016) Inhibition of SP1 by the mithramycin analog EC-8042 efficiently targets tumor initiating cells in sarcoma. *Oncotarget* 7: 30935–30950

Toulmonde M, Penel N, Adam J, Chevreau C, Blay J-Y, Le Cesne A, Bompas E, Piperno-Neumann S, Cousin S, Grellety T *et al* (2018) Use of PD-1 targeting, macrophage infiltration, and IDO pathway activation in sarcomas: a phase 2 clinical trial. *JAMA Oncol* 4: 93–97

Trama A, Badalamenti G, Baldi GG, Brunello A, Caira M, Drove N, Marrari A, Palmerini E, Vincenzi B, Dei Tos AP *et al* (2019) Soft tissue sarcoma in Italy: from epidemiological data to clinical networking to improve patient care and outcomes. *Cancer Epidemiol* 59: 258–264

Traub F, Griffin AM, Wunder JS, Ferguson PC (2018) Influence of unplanned excisions on the outcomes of patients with stage III extremity soft-tissue sarcoma. *Cancer* 124: 3868–3875

Trautmann M, Cheng Y-Y, Jensen P, Azoitei N, Brunner I, Hüllein J, Slabicki M, Isfort I, Cyra M, Berthold R *et al* (2019) Requirement for YAP1 signaling in myxoid liposarcoma. *EMBO Mol Med* 11: e9889

Trieb K, Lechleitner T, Lang S, Windhager R, Kotz R, Dirnhofer S (1998) Evaluation of HLA-DR expression and T-lymphocyte infiltration in osteosarcoma. *Pathol Res Pract* 194: 679–684

Tuncbilek N, Karakas HM, Okten OO (2005) Dynamic contrast enhanced MRI in the differential diagnosis of soft tissue tumors. *Eur J Radiol* 53: 500–505

Ulz P, Thallinger GG, Auer M, Graf R, Kashofer K, Jahn SW, Abete L, Pristauz G, Petru E, Geigl JB *et al* (2016) Inferring expressed genes by whole-genome sequencing of plasma DNA. *Nat Genet* 48: 1273–1278

Uotani K, Fujiwara T, Yoshida A, Iwata S, Morita T, Kiyono M, Yokoo S, Kunisada T, Takeda K, Hasei J *et al* (2017) Circulating MicroRNA-92b-3p as a novel biomarker for monitoring of synovial sarcoma. *Sci Rep* 7: 14634

Vaira V, Fedele G, Pyne S, Fasoli E, Zadra G, Bailey D, Snyder E, Faversani A, Coggi G, Flavin R *et al* (2010) Preclinical model of organotypic culture for pharmacodynamic profiling of human tumors. *Proc Natl Acad Sci USA* 107: 8352–8356

Vakkila J, Jaffe R, Michelow M, Lotze MT (2006) Pediatric cancers are infiltrated predominantly by macrophages and contain a paucity of dendritic cells: a major nosologic difference with adult tumors. *Clin Cancer Res* 12: 2049–2054

Vallette FM, Olivier C, Lézot F, Oliver L, Cochonneau D, Lalier L, Cartron P-F, Heymann D (2019) Dormant, quiescent, tolerant and persister cells: four synonyms for the same target in cancer. *Biochem Pharmacol* 162: 169–176

Varani J, Lovett EJ, Lundy J (1981) A model of tumor cell dormancy: effects of anesthesia and surgery. *J Surg Oncol* 17: 9–14

Varela-Guruceaga M, Tejada-Solís S, García-Moure M, Fueyo J, Gomez-Manzano C, Patiño-García A, Alonso MM (2018) Oncolytic viruses as therapeutic tools for pediatric brain tumors. *Cancers (Basel)* 10: 226

Vasan N, Baselga J, Hyman DM (2019) A view on drug resistance in cancer. *Nature* 575: 299–309

Vasquez L, León E, Beltran B, Maza I, Oscanoa M, Geronimo J (2017) Pretreatment neutrophil-to-lymphocyte ratio and lymphocyte recovery: independent prognostic factors for survival in pediatric sarcomas. *J Pediatr Hematol Oncol* 39: 538–546
Vaupel P, Okunieff P, Kallinowski F, Neuringer LJ (1989) Correlations between 31P-NMR spectroscopy and tissue O2 tension measurements in a murine fibrosarcoma. *Radiat Res* 120: 477-493

Vaupel P, Schaefer C, Okunieff P (1994) Intracellular acidosis in murine fibrosarcomas coincides with ATP depletion, hypoxia, and high levels of lactate and total Pi. *NMR Biomed* 7: 128-136

Visvader JE (2011) Cells of origin in cancer. *Nature* 469: 314-322

Vlachogiannis G, Hedayat S, Vatsiou A, Jamin Y, Fernández-Mateos J, Khan K, Lampis A, Eason K, Huntingford I, Burke R *et al* (2018) Patient-derived organoids model treatment response of metastatic gastrointestinal cancers. *Science* 359: 920-926

Vlenterie M, Oyen WJ, Steeghs N, Desar IME, Verheijen RB, Koenen AM, Grootjans W, DE Geus-Oei L-F, Van Erp NP, Van der Graaf WT (2019) Early metabolic response as a predictor of treatment outcome in patients with metastatic soft tissue sarcomas. *Anticancer Res* 39: 1309-1316

Volckmar A-L, Sültmann H, Riediger A, Fioretos T, Schirmacher P, Endris V, Stenzinger A, Dietz S (2018) A field guide for cancer diagnostics using cell-free DNA: from principles to practice and clinical applications. *Genes Chromosom Cancer* 57: 123-139

Vyse S, McCarthy F, Broncel M, Paul A, Wong JP, Bhamra A, Huang PH (2018) Quantitative phosphoproteomic analysis of acquired cancer drug resistance to pazopanib and dasatinib. *J Proteomics* 170: 130-140

Wacnik PW, Baker CM, Herron MJ, Kren BT, Blazar BR, Wilcox GL, Hordinsky MK, Beitz AJ, Ericson ME (2005) Tumor-induced mechanical hyperalgesia involves CGRP receptors and altered innervation and vascularization of DsRed2 fluorescent hindpaw tumors. *Pain* 115: 95-106

Wang M, Wang L, Ren T, Xu L, Wen Z (2013) IL-17A/IL-17RA interaction promoted metastasis of osteosarcoma cells. *Cancer Biol Ther* 14: 155-163

Watson S, Perrin V, Guillemot D, Reynaud S, Coindre J-M, Karanian M, Guinebretière J-M, Freneaux P, Loarer FL, Bouvet M *et al* (2018) Transcriptomic definition of molecular subgroups of small round cell sarcomas. *J Pathol* 245: 29-40

Watanabe S, Shimomura A, Kubo T, Sekimizu M, Seo T, Watanabe S-I, Kawai A, Yamamoto N, Tamura K, Kohno T *et al* (2020) BRAF V600E mutation is a potential therapeutic target for a small subset of synovial sarcoma. *Mod Pathol* 33: 1660-1668

Watson S, Perrin V, Guillemot D, Reynaud S, Coindre J-M, Karanian M, Guinebretière J-M, Freneaux P, Loarer FL, Bouvet M *et al* (2018) Transcriptomic definition of molecular subgroups of small round cell sarcomas. *J Pathol* 245: 29-40

Wei S, Henderson-Jackson E, Qian X, Bui MM (2017) Soft tissue tumor immunohistochemistry update: illustrative examples of diagnostic pearls to avoid pitfalls. *Arch Pathol Lab Med* 141: 1072-1091

Weidema ME, van de Geer E, Koelsche C, Desar IME, Kemmeren P, Hillebrandt-Roeffen MHS, Ho VKY, van der Graaf WTA, Versleijen-Jonkers YMH, von Deimling A *et al* (2020) DNA methylation profiling identifies distinct clusters in angiosarcomas. *Clin Cancer Res* 26: 93-100

Whelan JS, Davis LE (2018) Osteosarcoma, chondrosarcoma, and chordoma. *J Clin Oncol* 36: 188-193

WHO Classification of Tumours: Soft Tissue and Bone Tumours (2020). WHO Editorial Board WHO Classification of Tumours: Soft Tissue and Bone Tumours, 5th Ed. 978-92-8324502-5 (IARC).

Whyte WA, Orlando DA, Hnisz D, Abraham BJ, Lin CY, Kagey MH, Rahl PB, Lee TI, Young RA (2013) Master transcription factors and mediator establish super-enhancers at key cell identity genes. *Cell* 153: 307-319

Wilding CP, Elms ML, Judson I, Tan A-C, Jones RL, Huang PH (2019) The landscape of tyrosine kinase inhibitors in sarcomas: looking beyond pazopanib. *Expert Rev Anticancer Ther* 19: 971-991

Wilkinson MJ, Smith HG, Pencavel TD, Mansfield DC, Kyula-Currie J, Khan AA, McEntee G, Roulstone V, Hayes AJ, Harrington KJ (2016) Isolated limb perfusion with biochemotherapy and oncolytic virotherapy combines with radiotherapy and surgery to overcome treatment resistance in an animal model of extremity soft tissue sarcoma. *Int J Cancer* 139: 1414-1422

Witlox AM, Van Beusechem VW, Molenaar B, Bras H, Schaap GR, Alemany R, Curiel DT, Pinedo HM, Wuisman PIJM, Gerritsen WR (2004) Conditionally replicative adenovirus with tropism expanded towards integrins inhibits osteosarcoma tumor growth *in vitro* and *in vivo*. *Clin Cancer Res* 10: 61-67

Wolsztynski E, O'Sullivan F, Keyes E, O'Sullivan J, Eary JF (2018) Positron emission tomography-based assessment of metabolic gradient and other prognostic features in sarcoma. *J Med Imaging (Bellingham)* 5: 024502

Wu L-L, Tang M, Zhang Z-L, Qi C-B, Hu J, Ma X-Y, Pang D-W (2018) Chip-assisted single-cell biomarker profiling of heterogeneous circulating tumor cells using multifunctional nanospheres. *Anal Chem* 90: 10518-10526

Xiao H, Chen L, Luo G, Son H, Prectoni JH, Zheng W (2014) Effect of the cytokine levels in serum on osteosarcoma. *Tumour Biol* 35: 1023-1028

Xiao W, Mohseny AB, Hogendoorn PCW, Cleton-Jansen A-M (2013) Mesenchymal stem cell transformation and sarcoma genesis. *Clin Sarcoma Res* 3: 10

Xiao X, Wang W, Li Y, Yang D, Li X, Shen C, Liu Y, Ke X, Guo S, Guo Z (2018) HSP90AA1-mediated autophagy promotes drug resistance in osteosarcoma. *J Exp Clin Cancer Res* 37: 201

Xu J-F, Wang Y-P, Zhang S-J, Chen Y, Gu H-F, Dou X-F, Xia B, Bi Q, Fan S-W (2017) Exosomes containing differential expression of microRNA and mRNA in osteosarcoma that can predict response to chemotherapy. *Oncotarget* 8: 75968-75978

Yang Y, Han L, He Z, Li X, Yang S, Yang J, Zhang Y, Li D, Yang Y, Yang Z (2017) Advances in limb salvage treatment of osteosarcoma. *J Bone Oncol* 10: 36-40

Yoo C, Ryu M-H, Na YS, Ryoo B-Y, Park SR, Kang Y-K (2014) Analysis of serum protein biomarkers, circulating tumor DNA, and dovitinib activity in patients with tyrosine kinase inhibitor-refractory gastrointestinal stromal tumors. *Ann Oncol* 25: 2272-2277

Yu L, Fan Z, Fang S, Yang J, Gao T, Simões BM, Eyre R, Guo W, Clarke RB (2016) Cisplatin selects for stem-like cells in osteosarcoma by activating Notch signaling. *Oncotarget* 7: 33055-33068

Zeng W, Wan R, Zheng Y, Singh SR, Wei Y (2011) Hypoxia, stem cells and bone tumor. *Cancer Lett* 313: 129-136

Zhang H, Wu H, Zheng J, Yu P, Xu L, Jiang P, Gao J, Wang H, Zhang Y (2013) Transforming growth factor β1 signal is crucial for dedifferentiation of cancer cells to cancer stem cells in osteosarcoma. *Stem Cells* 31: 433-446

Zhang Z, Qiu Y, Hua Y, Wang Y, Chen T, Zhao A, Chi Y, Pan L, Hu S, Li J *et al* (2010) Serum and urinary metabonomic study of human osteosarcoma. *J Proteome Res* 9: 4861-4868

Zhitomirsky B, Assaraf YG (2016) Lysosomes as mediators of drug resistance in cancer. *Drug Resist Updat* 24: 23-33

Zhu R, Li X, Ma Y (2019) miR-23b-3p suppressing PGCIα promotes proliferation through reprogramming metabolism in osteosarcoma. *Cell Death Dis* 10: 381

<figure><img src="image_7.png" /></figure>

**License:** This is an open access article under the terms of the Creative Commons Attribution 4.0 License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.